Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesA retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine
Acta Psychiatrica Scandinavica, 10/15/09
Cormac I et al. – Abrupt cessation of smoking is associated with a potentially serious risk of toxicity in patients taking clozapine. Plasma clozapine levels must be monitored closely and adjustments made in dosage, if necessary, for at least six months after cessation.
Related Articles
A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy
Journal of Psychiatry & Neuroscience, 11/11/09
Relevance Score: 89%
Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia
Schizophrenia Research, 11/17/09
Relevance Score: 84%
In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation
British Journal of Clinical Pharmacology, 11/05/09
Relevance Score: 82%
Olanzapine-Induced Clinical Seizure: A Case Report
Clinical Neuropharmacology, 10/13/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/14/09
Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial)
Movement Disorders, 12/14/09
Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort
Dementia and Geriatric Cognitive Disorders, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor